Amendment SA2-AB56

AB56-SA2,39,7 87. Page 358, line 11: delete the material beginning with that line and ending with page 359, line 11, and substitute:

AB56-SA2,39,8 “ Section 728b. 50.03 (3) (b) (intro.) of the statutes is amended to read:

AB56-SA2,39,13 50.03 (3) (b) (intro.) The application for a license and, except as otherwise provided in this subchapter, the report of a licensee shall be in writing upon forms provided by the department and shall contain such information as the department requires, including the name, address and type and extent of interest of each of the following persons:

AB56-SA2,729b Section 729b. 50.03 (4) (c) 1. of the statutes is amended to read:

AB56-SA2,39,24 50.03 (4) (c) 1. A community-based residential facility license is valid until it is revoked or suspended under this section. Every 24 months, on a schedule determined by the department, a community-based residential facility licensee shall submit through an online system prescribed by the department a biennial report in the form and containing the information that the department requires, including payment of the fees required any fee due under s. 50.037 (2) (a). If a complete biennial report is not timely filed, the department shall issue a warning to the licensee. The department may revoke a community-based residential facility license for failure to timely and completely report within 60 days after the report date established under the schedule determined by the department.

AB56-SA2,730b Section 730b. 50.033 (2m) of the statutes is amended to read:

AB56-SA2,40,9 50.033 (2m) Reporting. Every 24 months, on a schedule determined by the department, a licensed adult family home shall submit through an online system prescribed by the department a biennial report in the form and containing the information that the department requires, including payment of the any fee required due under sub. (2). If a complete biennial report is not timely filed, the department shall issue a warning to the licensee. The department may revoke the license for failure to timely and completely report within 60 days after the report date established under the schedule determined by the department.”.

AB56-SA2,40,11 88. Page 359, line 22: delete the material beginning with that line and ending with page 360, line 9, and substitute:

AB56-SA2,40,12 “ Section 732b. 50.034 (2m) of the statutes is created to read:

AB56-SA2,40,21 50.034 (2m) Reporting. Every 24 months, on a schedule determined by the department, a residential care apartment complex shall submit through an online system prescribed by the department a report in the form and containing the information that the department requires, including payment of any fee required under sub. (1). If a complete report is not timely filed, the department shall issue a warning to the operator of the residential care apartment complex. The department may revoke a residential care apartment complex's certification or registration for failure to timely and completely report within 60 days after the report date established under the schedule determined by the department.”.

AB56-SA2,40,22 89. Page 363, line 8: after that line insert:

AB56-SA2,40,23 “ Section 746t. 51.03 (7) of the statutes is created to read:

AB56-SA2,41,4 51.03 (7) From the appropriation under s. 20.435 (5) (dg), the department shall award grants to regional crisis stabilization facilities for adults. The department shall establish criteria for a regional crisis stabilization facility to receive a grant under this subsection.”.

AB56-SA2,41,6 90. Page 364, line 14: delete the material beginning with that line and ending with page 365, line 8, and substitute:

AB56-SA2,41,7 “ Section 750b. 51.422 (1) of the statutes is amended to read:

AB56-SA2,41,15 51.422 (1) Program creation. The department shall create 2 or 3 new, regional comprehensive opioid treatment programs, and in the 2017-19 fiscal biennium, shall create 2 or 3 additional regional comprehensive opioid and methamphetamine treatment programs, to provide treatment for opioid and opiate addiction and methamphetamine addiction in underserved, high-need areas. The department shall obtain and review proposals for opioid and methamphetamine treatment programs in accordance with its request-for-proposal procedures. A program under this section may not offer methadone treatment.

AB56-SA2,751b Section 751b. 51.422 (2) of the statutes is amended to read:

AB56-SA2,42,2 51.422 (2) Program components. An opioid or methamphetamine treatment program created under this section shall offer an assessment to individuals in need of service to determine what type of treatment is needed. The program shall transition individuals to a certified residential program, if that level of treatment is necessary. The program shall provide counseling, medication-assisted treatment, including both long-acting opioid antagonist and partial agonist medications that have been approved by the federal food and drug administration if for treating opioid addiction, and abstinence-based treatment. The program shall transition individuals who have completed treatment to county-based or private post-treatment care.”.

AB56-SA2,42,3 91. Page 365, line 9: delete lines 9 to 16 and substitute:

AB56-SA2,42,4 “ Section 752b. 51.441 of the statutes is created to read:

AB56-SA2,42,11 51.441 Comprehensive mental health consultation program. The department shall convene a statewide group of interested persons, including at least one representative of the Medical College of Wisconsin, to develop a concept paper, business plan, and standards for a comprehensive mental health consultation program that incorporates general psychiatry, geriatric psychiatry, addiction medicine and psychiatry, a perinatal psychiatry consultation program, and the child psychiatry consultation program under s. 51.442.”.

AB56-SA2,42,12 92. Page 369, line 19: after that line insert:

AB56-SA2,42,13 “ Section 775i. 66.0137 (4) of the statutes is amended to read:

AB56-SA2,42,20 66.0137 (4) Self-insured health plans. If a city, including a 1st class city, or a village provides health care benefits under its home rule power, or if a town provides health care benefits, to its officers and employees on a self-insured basis, the self-insured plan shall comply with ss. 49.493 (3) (d), 631.89, 631.90, 631.93 (2), 632.728, 632.746 (1) and (10) (a) 2. and (b) 2., 632.747 (3), 632.798, 632.85, 632.853, 632.855, 632.867, 632.87 (4) to (6), 632.885, 632.89, 632.895 (9) (8) to (17), 632.896, and 767.513 (4).”.

AB56-SA2,42,21 93. Page 418, line 7: after that line insert:

AB56-SA2,42,22 “ Section 1686i. 120.13 (2) (g) of the statutes is amended to read:

AB56-SA2,43,2 120.13 (2) (g) Every self-insured plan under par. (b) shall comply with ss. 49.493 (3) (d), 631.89, 631.90, 631.93 (2), 632.728, 632.746 (1) and (10) (a) 2. and (b) 2., 632.747 (3), 632.798, 632.85, 632.853, 632.855, 632.867, 632.87 (4) to (6), 632.885, 632.89, 632.895 (9) (8) to (17), 632.896, and 767.513 (4).”.

AB56-SA2,43,4 94. Page 427, line 19: delete the material beginning with that line and ending with page 428, line 18, and substitute:

AB56-SA2,43,5 “ Section 1764b. 146.63 (2) (a) of the statutes is amended to read:

AB56-SA2,43,13 146.63 (2) (a) Subject to subs. (4) and (5), the department shall distribute grants from the appropriation under s. 20.435 (1) (fj) (4) (bf) to assist rural hospitals and groups of rural hospitals in procuring infrastructure and increasing case volume to the extent necessary to develop accredited graduate medical training programs. The department shall distribute the grants under this paragraph to rural hospitals and groups of rural hospitals that apply to receive a grant under sub. (3) and that satisfy the criteria established by the department under par. (b) and the eligibility requirement under sub. (6).

AB56-SA2,1765b Section 1765b. 146.63 (6) (intro.) of the statutes is amended to read:

AB56-SA2,43,18 146.63 (6) Eligibility. (intro.) A rural hospital or group of rural hospitals may only receive a grant under sub. (3) if the plan to use the funds involves developing an accredited graduate medical training program in any of the following specialties a specialty, including any of the following:

AB56-SA2,1766b Section 1766b. 146.64 (2) (c) 1. of the statutes is amended to read:

AB56-SA2,44,2 146.64 (2) (c) 1. The department shall distribute funds for grants under par. (a) from the appropriation under s. 20.435 (4) (b) (bf). The department may not distribute more than $225,000 from the appropriation under s. 20.435 (4) (b) (bf) to a particular hospital in a given state fiscal year and may not distribute more than $75,000 from the appropriation under s. 20.435 (4) (b) (bf) to fund a given position in a graduate medical training program in a given state fiscal year.

AB56-SA2,1767b Section 1767b. 146.64 (4) (intro.) of the statutes is amended to read:

AB56-SA2,44,6 146.64 (4) Eligibility. (intro.) A hospital that has an accredited graduate medical training program in any of the following specialties a specialty, including any of the following, may apply to receive a grant under sub. (3):”.

AB56-SA2,44,7 95. Page 430, line 15: after that line insert:

AB56-SA2,44,8 “ Section 1801i. 185.983 (1) (intro.) of the statutes is amended to read:

AB56-SA2,44,16 185.983 (1) (intro.) Every voluntary nonprofit health care plan operated by a cooperative association organized under s. 185.981 shall be exempt from chs. 600 to 646, with the exception of ss. 601.04, 601.13, 601.31, 601.41, 601.42, 601.43, 601.44, 601.45, 611.26, 611.67, 619.04, 623.11, 623.12, 628.34 (10), 631.17, 631.89, 631.93, 631.95, 632.72 (2), 632.728, 632.745 to 632.749, 632.775, 632.79, 632.795, 632.798, 632.85, 632.853, 632.855, 632.867, 632.87 (2) to (6), 632.885, 632.89, 632.895 (5) and (8) to (17), 632.896, and 632.897 (10) and chs. 609, 620, 630, 635, 645, and 646, but the sponsoring association shall:”.

AB56-SA2,44,17 96. Page 433, line 4: after that line insert:

AB56-SA2,44,18 “ Section 1891b. 250.048 of the statutes is created to read:

AB56-SA2,44,24 250.048 Prescription drug importation program. (1) Importation program requirements. The department, in consultation with persons interested in the sale and pricing of prescription drugs and appropriate officials and agencies of the federal government, shall design and implement a prescription drug importation program for the benefit of residents of this state, that generates savings for residents, and that satisfies all of the following:

AB56-SA2,45,3 (a) The department shall designate a state agency to become a licensed wholesale distributor or to contract with a licensed wholesale distributor and shall seek federal certification and approval to import prescription drugs.

AB56-SA2,45,6 (b) The prescription drug importation program under this section shall comply with relevant requirements of 21 USC 384, including safety and cost savings requirements.

AB56-SA2,45,9 (c) The prescription drug importation program under this section shall import prescription drugs from Canadian suppliers regulated under any appropriate Canadian or provincial laws.

AB56-SA2,45,12 (d) The prescription drug importation program under this section shall have a process to sample the purity, chemical composition, and potency of imported prescription drugs.

AB56-SA2,45,16 (e) The prescription drug importation program under this section shall import only those prescription drugs for which importation creates substantial savings for residents of the state and only those prescription drugs that are not brand-name drugs and that have fewer than 4 competitor prescription drugs in the United States.

AB56-SA2,45,19 (f) The department shall ensure that prescription drugs imported under the program under this section are not distributed, dispensed, or sold outside of the state.

AB56-SA2,45,21 (g) The prescription drug importation program under this section shall ensure all of the following:

AB56-SA2,45,23 1. Participation by any pharmacy or health care provider in the program is voluntary.

AB56-SA2,45,25 2. Any pharmacy or health care provider participating in the program has the appropriate license or other credential in this state.

AB56-SA2,46,3 3. Any pharmacy or health care provider participating in the program charges a consumer or health plan the actual acquisition cost of the imported prescription drug that is dispensed.

AB56-SA2,46,7 (h) The prescription drug importation program under this section shall ensure that a payment by a health plan or health insurance policy for a prescription drug imported under the program reimburses no more than the actual acquisition cost of the imported prescription drug that is dispensed.

AB56-SA2,46,10 (i) The prescription drug importation program under this section shall ensure that any health plan or health insurance policy participating in the program does all of the following:

AB56-SA2,46,12 1. Maintains a formulary and claims payment system with current information on prescription drugs imported under the program.

AB56-SA2,46,15 2. Bases cost-sharing amounts for participants or insureds under the plan or policy on no more than the actual acquisition cost of the prescription drug imported under the program that is dispensed to the participant or insured.

AB56-SA2,46,18 3. Demonstrates to the department or a state agency designated by the department how premiums under the policy or plan are affected by savings on prescription drugs imported under the program.

AB56-SA2,46,21 (j) Any wholesale distributor importing prescription drugs under the program under this section shall limit its profit margin to the amount established by the department or a state agency designated by the department.

AB56-SA2,46,24 (k) The prescription drug importation program under this section may not import any generic prescription drug that would violate federal patent laws on branded products in this country.

AB56-SA2,47,5 (L) The prescription drug importation program under this section shall comply to the extent practical and feasible before the prescription drug to be imported comes into possession of the state's wholesale distributor and fully after the prescription drug to be imported is in possession of the state's wholesale distributor with tracking and tracing requirements of 21 USC 360eee to 360eee-1.

AB56-SA2,47,8 (m) The prescription drug importation program under this section shall establish a fee or other approach to finance the program that does not jeopardize significant savings to residents of the state.

AB56-SA2,47,10 (n) The prescription drug importation program under this section shall have an audit function that ensures all of the following:

AB56-SA2,47,13 1. The department has a sound methodology to determine the most cost-effective prescription drugs to include in the importation program under this section.

AB56-SA2,47,15 2. The department has a process in place to select Canadian suppliers that are high quality, high performing, and in full compliance with Canadian laws.

AB56-SA2,47,17 3. Prescription drugs imported under the program are pure, unadulterated, potent, and safe.

AB56-SA2,47,19 4. The prescription drug importation program is complying with the requirements of this subsection.

AB56-SA2,47,22 5. The prescription drug importation program under this section is adequately financed to support administrative functions of the program while generating significant cost savings to residents of the state.

AB56-SA2,47,24 6. The prescription drug importation program under this section does not put residents of the state at a higher risk than if the program did not exist.

AB56-SA2,48,2 7. The prescription drug importation program under this section provides and is projected to continue to provide substantial cost savings to residents of the state.

AB56-SA2,48,5 (2) Anticompetitive behavior. The department, in consultation with the attorney general, shall identify the potential for and monitor anticompetitive behavior in industries affected by a prescription drug importation program.

AB56-SA2,48,16 (3) Approval of program design; certification. No later than the first day of the 7th month beginning after the effective date of this subsection .... [LRB inserts date], the department shall submit to the joint committee on finance a report that includes the design of the prescription drug importation program in accordance with this section. The department may not submit the proposed prescription drug importation program to the federal department of health and human services unless the joint committee on finance approves the proposed prescription drug implementation program. Within 14 days of the date of approval by the joint committee on finance of the proposed prescription drug importation program, the department shall submit to the federal department of health and human services a request for certification of the approved prescription drug importation program.

AB56-SA2,48,24 (4) Implementation of certified program. After the federal department of health and human services certifies the prescription drug importation program submitted under sub. (3), the department shall begin implementation of the program and the program shall be fully operational by 180 days after the date of certification by the federal department of health and human services. The department shall do all of the following to implement the prescription drug importation program to the extent the action is in accordance with other state laws and the certification by the federal department of health and human services:

AB56-SA2,49,3 (a) Become a licensed wholesale distributor, designate another state agency to become a licensed wholesale distributor, or contract with a licensed wholesale distributor.

AB56-SA2,49,5 (b) Contract with one or more Canadian suppliers that meet the criteria in sub. (1) (c).

AB56-SA2,49,9 (c) Create an outreach and marketing plan to communicate with and provide information to health plans and health insurance policies, employers, pharmacies, health care providers, and residents of the state on participating in the prescription drug importation program.

AB56-SA2,49,12 (d) Develop and implement a registration process for health plans and health insurance policies, pharmacies, and health care providers interested in participating in the prescription drug importation program.

AB56-SA2,49,14 (e) Create a publicly accessible source for listing prices of prescription drugs imported under the program.

AB56-SA2,49,17 (f) Create, publicize, and implement a method of communication to promptly answer questions from and address the needs of persons affected by the implementation of the program before the program is fully operational.

AB56-SA2,49,19 (g) Establish the audit functions under sub. (1) (n) with a timeline to complete each audit function every 2 years.

AB56-SA2,49,22 (h) Conduct any other activities determined by the department to be important to successful implementation of the prescription drug importation program under this section.

AB56-SA2,49,24 (5) Report. By January 1 and July 1 of each year, the department shall submit to the joint committee on finance a report including all of the following:

AB56-SA2,50,2 (a) A list of prescription drugs included in the importation program under this section.

AB56-SA2,50,5 (b) The number of pharmacies, health care providers, and health plans and health insurance policies participating in the prescription drug importation program under this section.

AB56-SA2,50,10 (c) The estimated amount of savings to residents of the state, health plans and health insurance policies, and employers resulting from the implementation of the prescription drug importation program under this section reported from the date of the previous report under this subsection and from the date the program was fully operational.

AB56-SA2,50,12 (d) Findings of any audit functions under sub. (1) (n) completed since the date of the previous report under this subsection.”.

AB56-SA2,50,13 97. Page 433, line 5: delete lines 5 to 11 and substitute:

AB56-SA2,50,14 “ Section 1892b. 250.10 (1m) (b) of the statutes is amended to read:

AB56-SA2,50,20 250.10 (1m) (b) Award in each fiscal year to qualified applicants grants totaling $25,000 no less than $50,000 for fluoride supplements, $25,000 for a fluoride mouth-rinse program varnish and other evidence-based oral health activities, $700,000 for school-based preventive dental services, and $120,000 for a school-based dental sealant program $100,000 for school-based restorative dental services.”.

AB56-SA2,50,22 98. Page 433, line 12: delete the material beginning with that line and ending with page 434, line 2, and substitute: